Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

CBRE Group Inc (CBG) Spikes to Record High; Check Out the Top Picks of One of Its Investors Cloud Gate Capital

Page 1 of 2

Brian Newman and David Heller’s Cloud Gate Capital, one of the newest additions to our database of more than 700 top hedge funds, was a big winner on Tuesday as a shareholder of CBRE Group Inc (NYSE:CBG), in which the fund holds 213,100 shares. Shares of the commercial real estate company were up over 6% yesterday, after it announced that it had acquired the Global Workplace Solutions business of Johnson Controls Inc (NYSE:JCI) for $1.48 billion in cash. We’ll check out that deal as well as take our first look at the top picks of Cloud Gate Capital.


The purchase by CBRE Group Inc (NYSE:CBG) has done nothing to dampen the enthusiasm in the company by investors and analysts, the latter having a consensus “Buy” rating on the stock. It adds 1.2 billion square feet of real estate space throughout 55 countries to the company’s portfolio, boosting it to nearly 5 billion square feet in total. In addition, CBRE Group Inc (NYSE:CBG) and Johnson Controls Inc (NYSE:JCI) announced a 10-year strategic partnership that among other things, will allow CBRE to purchase air conditioning equipment for its facilities directly from the factory of Johnson Controls.

However, the investor that has the highest payoff from CBRE’s stock jump is Richard Blum’s Blum Capital Partners, which is heavily invested in the stock, with 69.39% of its portfolio tied up in a 11.71 million share position in CBRE Group.

Cloud Gate Capital was added to our database this quarter, as the company filed a 13F for the first time last month, disclosing its equity portfolio at the end of 2014. Generally, institutional investors are required to file a 13F filing if the value of their equity portfolio exceeds $100 million. The fund’s equity portfolio stands at $100.02 million as of the end of last year and it is relatively diversified among 23 positions.

Even though some hedge funds manage to score big sometimes, the average return of equity hedge funds amounted to 1.4% in 2014, which is embarrassingly low compared to the S&P 500 ETF (SPY) gain of 13.5%. Our small-cap strategy of the top 15 small-cap stock picks of a select group of funds on the other hand returned 28.2% last year, and 53.2% in 2013. Moreover, since it was launched in August, 2012, our strategy has returned 132% through March 11, which 2.5 times higher than the 52.6% gain of the S&P 500 ETF (SPY) over the same period (see more details), proving unequivocally that there is immense value to be found in certain activity of hedge funds, even as they collectively underperform the market.

With this in mind, let’s move on to the top picks of Cloud Gate Capital from its first 13F filing. On the first spot is Brookdale Senior Living, Inc. (NYSE:BKD), in which the fund owns 262,600 shares valued at $9.63 million. This gives the fund one of the highest exposures to the stock, at 9.62% of its portfolio, with only Gunnar Overstrom’s Three Corner Global Investors having a greater exposure at 12.66%. Doug Silverman and Alexander Klabin’s Senator Investment Group is the largest shareholder among the funds we track with ownership of 9.15 million shares. Brookdale Senior Living, Inc. (NYSE:BKD) is up over 100% over the last three years, and more than 17% over the past calendar year. Despite that performance, activist investor Tom Sandell of Sandell Asset Management, has pushed for changes at the company, including a shakeup of Brookdale Senior Living, Inc. (NYSE:BKD)’s board and the nomination of himself and two other directors to it.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!